Found 60 matching trials
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)
PHASE3This study will determine whether participants who receive the vaccine V419...
Location
Multiple Locations
Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants
PHASE3This is a follow-up of the primary series vaccination schedule in Study A3L...
Location
Multiple Locations
Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants
PHASE3The purpose of this trial is to clinically confirm that the manufacturing p...
Location
Multiple Locations
Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers
PHASE3The purpose of this study is to evaluate safety and immunogenicity of Pedia...
Location
Multiple Locations
Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants
PHASE3The purpose of the study is to provide immunogenicity and safety data of th...
Location
Multiple Locations
Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV
PHASE3The present clinical study will assess the immunogenicity and reactogenicit...
Location
Multiple Locations
Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)
PHASE3This is a study to assess the safety, tolerability, and immunogenicity of V...
Location
Multiple Locations
Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy
N/AThe goal of this observational study is to learn about vaccine immunity in ...
Location
University Hospital Bern
Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea
N/AThe purpose of this study is to collect safety information following routin...
Location
GSK Investigational Site
Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects
PHASE3Infection with human papillomavirus (HPV) has been clearly established as t...
Location
GSK Investigational Site